menu
    • menu

    Company profile for Eupraxia Pharmaceuticals

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our patient-centric approach targets the areas of greatest need – where we can help patients and their healthcare providers achieve the best outcomes.Our focus goes beyond doing things right – we want to ensure we do the right things. Our experienced leadership inspires excellence at all levels – in ourselves, our team and our goals.We believe that creativity is more likely to happen in the right environment, so we have...
    Our patient-centric approach targets the areas of greatest need – where we can help patients and their healthcare providers achieve the best outcomes.Our focus goes beyond doing things right – we want to ensure we do the right things. Our experienced leadership inspires excellence at all levels – in ourselves, our team and our goals.We believe that creativity is more likely to happen in the right environment, so we have shaped a corporate culture that fosters ingenuity, passion and the freedom to explore.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eupraxia PharmaceuticalsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    201-2067 Cadboro Bay Rd. Victoria BC
    Telephone
    Telephone
    250-590-3968
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.eupraxiapharma.com/home/default.aspx
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eupraxia-pharmaceuticals-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/eupraxia_pharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eupraxia Pharma Reveals 6-Month Symptom Data In High-Dose Cohort
    Eupraxia Pharma Reveals 6-Month Symptom Data In High-Dose Cohort

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257002/0/en/Eupraxia-Pharmaceuticals-Reports-Six-Month-Symptom-Data-from-the-Highest-Dose-Cohort-in-its-Ongoing-Phase-1b-2a-RESOLVE-Trial-in-Eosinophilic-Esophagitis.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Eupraxia Pharma Sets US$55M Public Share Offering Pricing
    Eupraxia Pharma Sets US$55M Public Share Offering Pricing

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3240799/0/en/Eupraxia-Pharmaceuticals-Announces-Pricing-of-US-55-Million-Public-Offering-of-Common-Shares-and-Pre-Funded-Warrants.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Eupraxia Pharmaceuticals Announces Proposed Public Offering
    Eupraxia Pharmaceuticals Announces Proposed Public Offering

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240603/0/en/Eupraxia-Pharmaceuticals-Announces-Proposed-Public-Offering.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    Eupraxia Reports Near-Complete Biopsy Improvement in EoE Trial
    Eupraxia Reports Near-Complete Biopsy Improvement in EoE Trial

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215280/0/en/Eupraxia-Pharmaceuticals-Reports-Positive-Tissue-Health-Data-from-its-Ongoing-RESOLVE-Trial-in-Eosinophilic-Esophagitis-Demonstrating-Near-Complete-Improvement-on-Biopsy.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Eupraxia Pharma Reveals 52-Week RESOLVE Trial Follow-Up Data
    Eupraxia Pharma Reveals 52-Week RESOLVE Trial Follow-Up Data

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187915/0/en/Eupraxia-Pharmaceuticals-Reports-Additional-52-week-Follow-up-Data-from-the-RESOLVE-Trial-in-Eosinophilic-Esophagitis-EoE-Demonstrating-Consistent-Results-after-Dosing-with-EP-104G.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Eupraxia Pharma Reveals Q3 2025 Financials Updates
    Eupraxia Pharma Reveals Q3 2025 Financials Updates

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180937/0/en/Eupraxia-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search